Vanguard Group »

Immunome shares owned by Vanguard Group

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $35M 2.9M 12.10
2024-03-31 $50M 2.0M 24.68
2023-12-31 $19M 1.7M 10.70
2023-09-30 $3.3M 396k 8.35
2023-06-30 $3.0M 374k 7.91
2023-03-31 $1.9M 374k 4.99
2022-12-31 $826k 374k 2.21
2022-06-30 $1.2M 371k 3.21
2022-03-31 $2.1M 371k 5.68
2021-09-30 $9.1M 373k 24.35
2021-06-30 $5.2M 302k 17.26
2021-03-31 $5.2M 154k 33.83